The use of MRI, CT and lumbar puncture in dementia diagnostics: Data from the svedem registry

Dementia and Geriatric Cognitive Disorders

Volumn 39, Issue , 2015, Pages 81-91

  Falahati, Farshad ^a   Fereshtehnejad, Seyed Mohammad ^a   Religa, Dorota ^a,b,c   Wahlund, Lars Olof ^a,c   Westman, Eric ^a   Eriksdotter, Maria ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Care Sciences and Society ^*  (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Clinical practice pattern; Dementia and imaging; Differential diagnosis

Indexed keywords

BIOLOGICAL MARKER;

AGE; AGED; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY ASSESSMENT; EPIDEMIOLOGY; FEMALE; GENDER; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUNCTURE; REGISTER; SWEDEN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; DEMENTIA; DIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; EPIDEMIOLOGY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; REGISTRIES; SPINAL PUNCTURE; SWEDEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84964265798     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000366194     Document Type: Article

References (33)

1. Albert M, DeCarli C, DeKosky S, Leon MD, Foster NL, Fox N, et al: The use of MRI and PET for clinical diagnosis of dementia and investigation of cognitive impairment: a consensus report. Neuroimaging Work Group of the Alzheimers Association, 2005.
2. Zetterberg H, Blennow K: Cerebrospinal fluid biomarkers for Alzheimers disease: more to come? J Alzheimers Dis 2013; 33(suppl 1):S361-S369.
3. Le Bastard N, Martin JJ, Vanmechelen E, Vanderstichele H, De Deyn PP, Engelborghs S: Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Neurobiol Aging 2010; 31: 1867-1876.
4. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al: Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-1153.
5. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al: Recommendations for the diagnosis and management of Alzheimers disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007; 14:e1-e26.
6. Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, et al: EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012; 19: 1159-1179.
7. Nationella riktlinjer för vard och omsorg vid demenssjukdom 2010: stöd för styrning och ledning [National Guidelines for Care in Cases of Dementia]. Stockholm, Socialstyrelsens, 2010.
8. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al: The diagnosis of dementia due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement 2011; 7: 263-269.
9. van Straaten EC, Scheltens P, Barkhof F: MRI and CT in the diagnosis of vascular dementia. J Neurol Sci 2004; 226: 9-12.
10. Paraskevas GP, Kapaki E, Papageorgiou SG, Kalfakis N, Andreadou E, Zalonis I, et al: CSF biomarker profile and diagnostic value in vascular dementia. Eur J Neurol 2009; 16: 205-211.
11. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al: Dementia with Lewy bodies. Lancet Neurol 2004; 3: 19-28.
12. McKeith IG: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 2006; 9(suppl 3):417-423.
13. Aarsland D, Kurz M, Beyer M, Bronnick K, Piepenstock Nore S, Ballard C: Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers. Dement Geriatr Cogn Disord 2008; 25: 195-205.
14. Small GW: Neuroimaging as a diagnostic tool in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2004; 17(suppl 1):25-31.
15. Watson R, Blamire AM, OBrien JT: Magnetic resonance imaging in Lewy body dementias. Dement Geriatr Cogn Disord 2009; 28: 493-506.
16. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994; 57: 416-418.
17. Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, et al: CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimers disease and controls. Dement Geriatr Cogn Disord 2007; 23: 225-230.
18. Johnell K, Religa D, Eriksdotter M: Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients. Dement Geriatr Cogn Disord 2013; 35: 239-248.
19. Fereshtehnejad SM, Johnell K, Eriksdotter M: Anti-dementia drugs and co-medication among patients with Alzheimers disease: investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem). Drugs Aging 2014; 31: 215-224.
20. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. London, Royal College of Psychiatrists, 1992.
21. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al: Clinical diagnostic criteria for dementia associated with Parkinsons disease. Mov Disord 2007; 22: 1689-1707, quiz 1837.
22. Wattjes MP, Henneman WJP, van der Flier WM, de Vries O, Trber F, Geurts JJG, et al: Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology 2009; 253: 174-183.
23. Johannsen P, Jrgensen K, Krner A, Elmo EG, Lauesen LB, Utzon J: Development of a dementia assessment quality database. Aging Ment Health 2011; 15: 40-46.
24. Religa D, Spangberg K, Wimo A, Edlund AK, Winblad B, Eriksdotter-Jonhagen M: Dementia diagnosis differs in men and women and depends on age and dementia severity: data from SveDem, the Swedish Dementia Quality Registry. Dement Geriatr Cogn Disord 2012; 33: 90-95.
25. Eriksson H, Fereshtehnejad SM, Falahati F, Farahmand B, Religa D, Eriksdotter M: Differences in routine clinical practice between early and late onset Alzheimers disease: data from the Swedish Dementia Registry (SveDem). J Alzheimers Dis 2014; 41: 411-419.
26. Whitwell JL, Jack CR Jr: Neuroimaging in dementia. Neurol Clin 2007; 25: 843-857, viii.
27. Vitali P, Migliaccio R, Agosta F, Rosen HJ, Geschwind MD: Neuroimaging in dementia. Semin Neurol 2008; 28: 467-483.
28. Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, et al: Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimers disease. Brain 2007; 130: 708-719.
29. Fereshtehnejad SM, Religa D, Westman E, Aarsland D, Lökk J, Eriksdotter M: Comparison of dementia with Lewy bodies with Parkinsons disease dementia in the Swedish Dementia Quality Registry (SveDem). Neuropsychiatr Dis Treat 2013; 9: 1-9.
30. Blennow K, Wallin A, Hager O: Low frequency of post-lumbar puncture headache in demented patients. Acta Neurol Scand 1993; 88: 221-223.
31. Mattsson N, Rosen E, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al: Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 2012; 78: 468-476.
32. Wimo A, Religa D, Spangberg K, Edlund AK, Winblad B, Eriksdotter M: Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry. Int J Geriatr Psychiatry 2013; 28: 1039-1044.
33. SveDem Svenska Demensregistret rsrapport 2012 [SveDem annual report 2012]. 2013 [Dec 2013]. http://www.ucr.uu.se/svedem/index.php/om-svedem/arsrapporter.